Clin2
NCT07691801Possibly a fitRecruiting

Testing a New Method to Diagnose a Common Cause of High Blood Pressure

Primary Aldosteronism

Part of Hormones & metabolism clinical trials.

This study uses a new, precise blood test to help diagnose primary aldosteronism, a condition where the adrenal glands make too much of a hormone that raises blood pressure. It compares results from healthy volunteers and patients with suspected primary aldosteronism to see if it works better than current methods.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
800 people
Ages
18 years to 70 years
Study type
Observational

Who can take part

  • You are between 18 and 70 years old.
  • For healthy volunteers: your blood pressure is between 100-120/60-80 mmHg and you have no history of high blood pressure.
  • For patients with suspected primary aldosteronism: your doctor suspects you have this condition and you are willing to take spironolactone for 4 weeks.
  • Your body mass index (BMI) is between 18.5 and 23.9 if you are a healthy volunteer.
  • You have no history of liver or kidney problems, heart disease, diabetes (if poorly controlled), or certain other illnesses.
  • You are not taking medicines that affect the renin-angiotensin system (like some contraceptives, steroids, or diabetes drugs).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07635134Recruiting
Testing a new method to diagnose primary aldosteronism

This study is developing a better blood test to diagnose primary aldosteronism, a condition where the adrenal glands produce too much of a hormone called aldosterone, causing high blood pressure. Researchers are comparing results from healthy volunteers and patients suspected of having this condition to find the right cutoff numbers for the new test.

Beijing, Beijing Municipality
NCT06750172Recruiting
Shorter salt test for primary aldosteronism diagnosis

This study tests if a 2-day version of the oral salt loading test works as well as the standard 3-day test to diagnose primary aldosteronism (a common cause of high blood pressure). If effective, it could make diagnosis faster and easier for patients.

Beijing, Beijing Municipality
NCT07111351Recruiting
Studying hormones and genes in adrenal gland conditions

This study looks at the genes and molecules in people with primary aldosteronism (a condition where the adrenal glands make too much of the hormone aldosterone), primary hypertension (high blood pressure), and healthy volunteers. The goal is to better understand these conditions and find better ways to diagnose and treat them.

Beijing, Beijing Municipality
NCT06941116Recruiting
Steroid test to screen for a common cause of high blood pressure

This trial tests whether a simple steroid-based test can help identify a specific type of high blood pressure called primary aldosteronism. If you have high blood pressure that needs medication, this study may help find a treatable cause.

Chongqing, Chongqing Municipality
NCT07621458Recruiting
Primary Aldosteronism Blood Test Measurement Study

This study examines how different methods of measuring hormone levels in the blood help identify primary aldosteronism (a condition causing high blood pressure). Researchers want to find the best cutoff values to identify patients who might benefit from surgery to remove part of the adrenal gland.

Seoul, Korea, Republic of
NCT06756737Not yet recruiting
Special PET/MR scans for primary aldosteronism

This study uses special PET/MR scans to take detailed pictures of the adrenal glands (small glands on top of your kidneys) to help find the cause of primary aldosteronism (a condition where these glands make too much of a hormone that raises blood pressure). The scans may help doctors see which adrenal gland is causing the problem, which can guide treatment.

Hear when a new Primary Aldosteronism trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.